HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Balistreri Selected Research

apilimod

10/2021Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
8/2021Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Balistreri Research Topics

Disease

4Infections
06/2022 - 01/2021
2COVID-19
10/2021 - 08/2021

Drug/Important Bio-Agent (IBA)

3Peptide Hydrolases (Proteases)FDA Link
06/2022 - 08/2021
3Proteins (Proteins, Gene)FDA Link
06/2022 - 08/2021
2CathepsinsIBA
10/2021 - 08/2021
2Pharmaceutical PreparationsIBA
10/2021 - 08/2021
2Phosphotransferases (Kinase)IBA
10/2021 - 08/2021
2nafamostatIBA
10/2021 - 08/2021
2camostatIBA
10/2021 - 08/2021
2apilimodIBA
10/2021 - 08/2021
1Capsid Proteins (Capsid Protein)IBA
01/2021